Submitted by Anonymous (not verified) on 28 October 2026 - 13:30
Human medicines European public assessment report (EPAR): Lamivudine Teva Pharma B.V., lamivudine, Date of authorisation: 10/12/2009, Revision: 20, Status: Authorised
Source: